MetaCap

Scholar Rock Cash Flow Statement

NASDAQ: SRRKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

42.19-0.01 (-0.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Scholar Rock free cash flow

In fiscal 2025, Scholar Rock generated -$300.0 million of operating cash flow and spent $602,000 on capital expenditures. That left free cash flow of -$300.6 million.

Summary generated from market data by MetaCap's automated system. Methodology

Scholar Rock cash flow statement (annual)

Scholar Rock annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Net Income-377.94M-246.29M-165.79M-134.50M-131.80M-86.48M-51.00M-49.33M-25.00M
Net Income growth (YoY)—————————
Depreciation & Amortization1.66M1.94M2.84M2.99M2.63M1.49M1.30M807.00K669.00K
Stock-Based Compensation75.60M36.63M27.14M27.70M23.15M11.18M7.97M5.21M1.48M
Change in Working Capital5.01M11.39M74.00K-26.88M-22.67M13.43M-20.12M67.65M1.47M
Operating Cash Flow-300.04M-200.95M-145.23M-132.69M-126.79M-60.27M-63.12M24.57M-21.74M
Capital Expenditures-602.00K-98.00K-71.00K-1.06M-5.25M-4.09M-3.12M-1.49M-361.00K
Investing Cash Flow218.69M-76.06M41.14M-171.70M134.31M-63.50M-62.24M-60.23M17.66M
Debt Issued24.67M———24.98M24.62M———
Debt Repaid-25.52M—————-365.00K-667.00K—
Financing Cash Flow228.40M353.03M102.57M194.83M44.95M247.82M48.88M94.27M50.50M
Net Change in Cash147.05M76.02M-1.51M-109.56M52.48M124.05M-76.47M58.61M46.43M
Free Cash Flow-300.64M-201.05M-145.30M-133.76M-132.04M-64.36M-66.23M23.08M-22.10M

This table shows 9 annual periods of Scholar Rock's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SRRK's reporting calendar. What is a cash flow statement?

More financial data